The menin encoding gene (MEN1) and pathogeny of MEN1-related digestive neuroendocrine tumors;Le gène de la ménine (NEM1) et la physiopathogénie des tumeurs neuroendocrines digestives associées à la NEM1

Medecine et Hygiene

Volumn 59, Issue 2358, 2001, Pages 1654-1662

  Calender, Alain ^a   Vercherat, C ^a   Cordier, M ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0242504909     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positionnal cloning of the gene for multiple endocrine neoplasia type 1. Science 1997; 276: 404-7.
2. The European Consortium on MEN1. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. Hum Mol Genet 1997; 6: 1177-83.
3. Stewart C, Parente F, Piehl F, et al. Characterization of the mouse MEN1 gene and its expression during development. Oncogene 1998; 17: 2485-93.
4. Guru SC, Goldsmith PK, Bums AL, et al. Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci USA 1998; 95: 1630-4.
5. Huang SC, Zhuang Z, Weil RJ, et al. Nuclear/cytoplasmic localization of the multiple endocrine neoplasia type 1 gene product, menin. Lab Invest 1999; 79: 301-10.
6. Knudson AG Jr. Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 820-3.
7. Kim YS, Bums AL, Goldsmith PK, et al. Stable overexpression of MEN1 suppresses tumorigenicity of Ras. Oncogene 1999; 18: 5936-42.
8. Agarwal SK, Guru SC, Heppner C, et al. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 1999; 96: 143-52.
9. Kaji H, Canaff L, Lebrun JJ, Goltzman D, Hendy GN. Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling. Proc Natl Acad Sci USA 2001; 98: 3837-42.
10. Ohkura N, Kishi M, Tsukada T, Yamaguchi K. Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor, nm23. Biochem Biophys Res Comm 2001; 282: 1206-10.
11. Liberati NT, Datto MB, Frederick JP, et al. Smads bind directly to the Jun family of AP-1 transcription factors. Proc Natl Acad Sci USA 1999; 96: 4844-9.
12. Sakurai A, Katai M, Itakura Y, et al. Premature centromere division in patients with multiple endocrine neoplasia type 1. Cancer Genet Cytogenet 1999; 109: 138-40.
13. Zimering MB, Katsumata N, Friesen HG, et al. Fibroblast growth factor-like autoantibodies in plasma from patients with multiple endocrine neoplasia type 1 and prolactinoma. Ann N Y Acad Sci 1997; 815: 520-3.
14. Agarwal S, Kester MB, Debelenko LV, et al. Germline mutations of the MEN1 gene in familial MEN1 and related states. Hum Mol Genet 1997; 6: 1169-75.
15. Bassett JHD, Forbes SA, Pannett AAJ, et al. Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet 1998; 62: 232-44.
16. Giraud S, Zhang CX, Serova-Sinilnikova O, et al. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Am J Hum Genet 1998; 63: 455-67.
17. Wautot V, Khodaei S, Frappart L, et al. Expression analysis of endogenous menin, the product of the multiple endocrine neoplasia type 1 gene, in cell lines and human tissues. Int J Cancer 2000; 85: 877-81.
18. Kassem M, Kruse TA, Wong FK, et al. Familial isolated hyperparathyroidism as a variant of multiple endocrine neoplasia type 1 in a large Danish pedigree. J Clin Endoc Metab 2000; 85: 165-7.
19. Brown EM. Mutations in the calcium-sensing receptor and their clinical implications. Horm Res 1997; 48: 199-208.
20. Wassif WS, Farnebo F, Teh BT, et al. Genetic studies with hereditary hyperparathyroidism-jaw tumor syndrome. Clin Endocrinol 1999; 50: 191-6.
21. Crabtree J, Scacheri PC, Ward JM, et al. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA 2001; 98: 1118-23.
22. Heppner C, Kester MB, Agarwal SK, et al. Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet 1997; 16: 375-7.
23. Toliat MR, Berger W, Ropers HH, et al. Mutations in the MEN1 gene sporadic neuroendocrine tumours of gastroenteropancreatic system. Lancet 1997; 350: 1223.
24. Zhuang ZP, Vortmeyer AO, Pack S, et al. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res 1997; 57: 4682-6.
25. Debelenko LV, Brambilla E, Agarwal SK, et al. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 1997; 6: 2285-90.
26. Zhuang Z, Ezzat SZ, Vortmeyer AO, et al. Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res 1997; 57: 5446-51.
27. Gortz B, Roth J, Speel EJ, et al. MEN1 gene mutation analysis of sporadic adrenocortical lesions. Int J Cancer 1999; 80: 373-9.
28. Murgia A, Martella M, Vinanzi C, et al. Somatic mosaicism in von Hippel-Lindau Disease. Hum Mutat 2000; 15: 114.
29. Verhoef S, Bakker L, Tempelaars AM, et al. High rate of mosaicism in tuberous sclerosis complex. Am J Hum Genet 1999; 64: 1632-7.
30. Pal T, Liede A, Mitchell M, et al. Intestinal carcinoid tumours in a father and daughter. Can J Gastroenterol 2001; 15: 405-9.
31. Oliveira AM, Tazelaar HD, Wentzlaff KA, et al. Familial pulmonary carcinoid tumors. Cancer 2001; 91: 2104-9.
32. Tanaka C, Yoshimoto K, Yamada S, et al. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese. J Clin Endoc Metab 1998; 83: 960-5.
33. Ferretti E, Jaffrain Rea ML, Asteria C, et al. Two familial giant pituitary adenomas associated with over weight: Clinical, morphological and genetic features. Eur J Endocrinol 2001; 44: 227-35.